Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.71)
# 756
Out of 5,028 analysts
141
Total ratings
51.9%
Success rate
23.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintained: Buy | $6 | $2.98 | +101.34% | 13 | Oct 5, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $4 | $0.5641 | +609.09% | 33 | Aug 6, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Hold | n/a | $0.3798 | - | 14 | Jan 12, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $4.91 | +1,122.00% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $2.00 | +150.00% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $22.54 | +290.42% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $9 | $2.56 | +251.56% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | $22 | $2.96 | +643.24% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $85 → $84 | $73.00 | +15.07% | 14 | Nov 5, 2025 | |
| LQDA Liquidia | Reiterated: Buy | $54 → $67 | $28.64 | +133.94% | 22 | Nov 3, 2025 |
Prime Medicine
Oct 5, 2026
Maintained: Buy
Price Target: $6
Current: $2.98
Upside: +101.34%
Tenaya Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.5641
Upside: +609.09%
Mereo BioPharma Group
Jan 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3798
Upside: -
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $4.91
Upside: +1,122.00%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Tectonic Therapeutic
Nov 18, 2025
Reiterated: Buy
Price Target: $88
Current: $22.54
Upside: +290.42%
Rocket Pharmaceuticals
Nov 7, 2025
Reiterated: Buy
Price Target: $9
Current: $2.56
Upside: +251.56%
Larimar Therapeutics
Nov 5, 2025
Reiterated: Buy
Price Target: $22
Current: $2.96
Upside: +643.24%
Tarsus Pharmaceuticals
Nov 5, 2025
Reiterated: Buy
Price Target: $85 → $84
Current: $73.00
Upside: +15.07%
Liquidia
Nov 3, 2025
Reiterated: Buy
Price Target: $54 → $67
Current: $28.64
Upside: +133.94%